Niki BioSolutions, Inc. (NIKI) vs Zhongchao Inc. (ZCMD)

A side-by-side comparison of Niki BioSolutions, Inc. and Zhongchao Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — NIKI vs ZCMD

growth of $100 · dividends reinvested · last 7y
NIKI -100.0% (-68.1%/yr)ZCMD -100.0% (-77.2%/yr)NIKI compounded faster over this window
Log scale — wide-divergence pair
0001101001kStart $100202120222023202420252026$0$0
NIKI ZCMD

NIKI vs ZCMD: by the numbers

  • •NIKI is the larger company ($401484 vs $30736 market cap).
  • •Both run net losses; NIKI's is the smaller (0.00% vs -55.47% net margin).

Metrics side by side

Valuation

MetricNIKIZCMD
P/B ratio0.020.00

Profitability

MetricNIKIZCMD
Gross margin0.00%42.47%
Operating margin0.00%-54.43%
Net margin0.00%-55.47%
ROE-5.89%-33.87%
ROIC-10.38%-27.17%

Growth (annualized)

MetricNIKIZCMD
Revenue CAGR (5Y)N/A-8.76%
Total return CAGR (5Y)-71.40%-84.76%

Frequently asked

How have NIKI and ZCMD total returns compared?
Over the past 5 years, NIKI delivered -71.40% and ZCMD delivered -84.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.